Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer : an EORTC-NCIC-SAKK multicenter study
Nom du journal : J Clin Oncol
Année : 2003
Volume : 21
Page de départ : 843
Page de fin : 850